<DOC>
	<DOCNO>NCT02474342</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Autologous Adipose Tissue Derived Mesenchymal Stem Cells injection patient Rotator Cuff disease .</brief_summary>
	<brief_title>Autologous Adipose Tissue Derived Mesenchymal Stem Cells Rotator Cuff Disease</brief_title>
	<detailed_description />
	<criteria>Participants meet inclusion criterion . Patients must consent write participate study sign date informed consent document approve IRB indicate patient inform pertinent aspect study prior complete screen procedure 1 . Male female 19 year age old . 2 . Patients unilateral shoulder pain . 3 . Patients pain least 3 month respond conservative treatment . 4 . Patients partialthickness rotator cuff tear confirm magnetic resonance imaging ( MRI ) ultrasonography ( US ) . Participants meet single condition exclude study 1 . Patients receive drug subacromial injection treatment within 3 month prior enrollment . 2 . Patients history shoulder trauma include dislocation , subluxation , fracture , breast cancer , surgery around shoulder , neck upper back within 6 month prior enrollment . 3 . Patients fullthickness rotator cuff tear 4 . Patients radiological finding malignancy , osteoarthritis glenohumeral joint , skeletal abnormality decrease subacromial space 5 . Patients symptomatic cervical spine disorder 6 . Patients concurrent bilateral shoulder pain 7 . Patients adhesive capsulitis , acromioclavicular arthropathy , polyarthritis , infectious arthritis , rheumatoid arthritis diagnose fibromyalgia 8 . Patients neurological deficit 9 . Pregnant woman lactate mother 10 . Fertile woman childbearing potential willing use adequate contraception study duration 11 . Patients take anticoagulant 12 . Patients positive serology human immunodeficiency ( HIV ) , hepatitis B ( HBV ) hepatitis C ( HCV ) syphilis 13 . Patients serious condition affect study severe cardiovascular disease , renal disease , liver disease , endocrine disease , cancer 14 . Patients difficulty participate data collection due communication problem serious mental illness 15 . Patients unable come clinic regular followup 16 . Patients participate clinical trial within 3 month prior study . 17 . Patients principal investigator consider inappropriate clinical trial due reason list .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>